Invention Grant
- Patent Title: 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators
-
Application No.: US15618504Application Date: 2017-06-09
-
Publication No.: US10246432B2Publication Date: 2019-04-02
- Inventor: John Andrew Christopher , Miles Stuart Congreve , Sarah Joanne Aves , Benjamin Gerald Tehan
- Applicant: Heptares Therapeutics Limited
- Applicant Address: GB Welwyn Garden
- Assignee: Heptares Therapeutics Limited
- Current Assignee: Heptares Therapeutics Limited
- Current Assignee Address: GB Welwyn Garden
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Mei Bai
- Priority: GB1312800.4 20130717
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D403/04 ; C07D239/26
Abstract:
The disclosures herein relate to novel compounds of formula wherein R1, R2, R3 and R4 and n are defined herein, and their use in treating, preventing, ameliorating, controlling or reducing the risk of inflammation, neurological or psychiatric disorders associated with modulating mGlu5 receptor function.
Public/Granted literature
- US20170275265A1 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS Public/Granted day:2017-09-28
Information query
